Thermo Fisher Scientific (TMO) Tops Q4 EPS by $1.61

Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $6.54, $1.61 better than the analyst estimate of $4.93. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $8.84 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c
• Palo Alto Networks (PANW) PT Raised to $400 at TD Cowen